EXOR GROUP – Consolidated Statement of Financial Position - Shortened
| € million | Note | 12/31/2012 | 12/31/2011 | Change | |
|---|---|---|---|---|---|
| Non-current assets | |||||
| Investments accounted for using the equity method | 7 | 5.005,3 | 4.822,6 | 182,7 | |
| Other financial assets: | |||||
| - Investments measured at fair value | 8 | 2.236,3 | 1.734,6 | 501,7 | |
| - Other investments | 9 | 544,4 | 206,5 | 337,9 | |
| - Other financial assets | 15,6 | (a) | 1,0 | 14,6 | |
| Other property, plant and equipment and intangible assets | 0,3 | 0,7 | (0,4) | ||
| Total Non-current assets | 7.801,9 | 6.765,4 | 1.036,5 | ||
| Current assets | |||||
| Financial assets and cash and cash equivalents | 11 | 752,0 | 701,0 | 51,0 | |
| Tax receivables and other receivables | 5,8 | 27,5 | (21,7) | ||
| Total Current assets | 757,8 | 728,5 | 29,3 | ||
| Non-current assets held for sale | 7,4 | (b) | 70,3 | (62,9) | |
| Total Assets | 8.567,1 | 7.564,2 | 1.002,9 | ||
| Issued capital and reserves attributable to owners of the parent | 10 | 7.164,4 | 6.403,4 | 761,0 | |
| Non-current liabilities | |||||
| Bonds and other financial debt | 11 | 1.279,5 | 1.045,8 | 233,7 | |
| Provisions for employee benefits | 2,4 | 2,2 | 0,2 | ||
| Deferred tax liabilities, other liabilities and provisions for risk | 6,4 | (c) | 6,5 | (0,1) | |
| Total Non-current liabilities | 1.288,3 | 1.054,5 | 233,8 | ||
| Current liabilities | |||||
| Bonds, bank debt and other financial liabilities | 11 | 108,5 | 96,3 | 12,2 | |
| Other liabilities | 5,9 | 10,0 | (4,1) | ||
| Total Current liabilities | 114,4 | 106,3 | 8,1 | ||
| Total Equity and Liabilities | 8.567,1 | 7.564,2 | 1.002,9 |
(a) Includes mainly the financial receivable by EXOR from Alpitour for €14.7 million, which is the remaining balance of the Deferred Price on the sale of Alpitour (€15 million), inclusive of interest capitalized during the year (€0.8 million) calculated using an annual 8% interest rate and adjusted by expenses (€1.1 million) for the settlement of certain disputes that arose with the buyer in the period subsequent to acquisition and relating to events prior to the sale by EXOR. This receivable is not included in the net financial position balance.
(b) Relates to the measurement of Perfect Vision convertible bonds and the embedded derivative instrument, carried out on the basis of the criteria set out in the sales agreement signed on December 23, 2011 by EXOR S.A. and Vision Investment Management Ltd., subsequently modified in the early months of 2013.
(c) Includes the estimate of expenses for €3.5 million provided for the disputes which arose with the Alpitour buyer in the period subsequent to acquisition and relating to events prior to the sale by EXOR, which presumably will be settled during 2013.
Related links
